Scarica l'app Stockscreener
17.03
12.56%
1.90
Pre-mercato:
16.45
-0.58
-3.41%
Precedente Chiudi:
$15.13
Aprire:
$15.25
Volume 24 ore:
1.21M
Relative Volume:
0.77
Capitalizzazione di mercato:
$529.06M
Reddito:
-
Utile/perdita netta:
$-49.81M
Rapporto P/E:
-7.8989
EPS:
-2.156
Flusso di cassa netto:
$-42.93M
1 W Prestazione:
+23.05%
1M Prestazione:
+40.63%
6M Prestazione:
+606.64%
1 anno Prestazione:
+344.65%
Intervallo 1D:
$15.00
$17.61
Intervallo di 1 settimana:
$12.51
$17.61
Portata 52W:
$1.60
$17.61
Alto Neuroscience Inc Stock (ANRO) Company Profile
Nome
Alto Neuroscience Inc
Settore
Industria
Telefono
773-255-5012
Indirizzo
650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW
Confronta ANRO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANRO
Alto Neuroscience Inc
|
17.03 | 470.03M | 0 | -49.81M | -42.93M | -2.156 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alto Neuroscience Inc Stock (ANRO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-17 | Iniziato | BTIG Research | Buy |
| 2025-09-29 | Iniziato | Chardan Capital Markets | Buy |
| 2024-10-23 | Downgrade | Rodman & Renshaw | Buy → Neutral |
| 2024-10-23 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-09-03 | Iniziato | Wedbush | Outperform |
| 2024-02-27 | Iniziato | Jefferies | Buy |
| 2024-02-27 | Iniziato | Robert W. Baird | Outperform |
| 2024-02-27 | Iniziato | Stifel | Buy |
| 2024-02-27 | Iniziato | TD Cowen | Outperform |
| 2024-02-27 | Iniziato | William Blair | Outperform |
Mostra tutto
Alto Neuroscience Inc Borsa (ANRO) Ultime notizie
Alto Neuroscience (NYSE:ANRO) Sets New 12-Month HighShould You Buy? - MarketBeat
Alto Neuroscience, Inc. $ANRO Shares Sold by AWM Investment Company Inc. - MarketBeat
Market Trends: Is Alto Neuroscience Inc stock recession proofDay Trade & Verified Swing Trading Watchlist - moha.gov.vn
ANRO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Can Alto Neuroscience Inc. stock maintain growth trajectoryWeekly Loss Report & Technical Analysis for Trade Confirmation - Newser
Will Alto Neuroscience Inc. stock announce special dividendWeekly Trade Summary & Verified Momentum Watchlists - Newser
Aug Wrap: Is Alto Neuroscience Inc. stock supported by strong fundamentalsJuly 2025 News Drivers & Precise Swing Trade Alerts - BỘ NỘI VỤ
What insider purchases suggest about Alto Neuroscience Inc. stockQuarterly Portfolio Report & AI Enhanced Trade Execution Alerts - Newser
Alto Neuroscience Announces New Employee Inducement Grants Under NYSE Rule 303A.08December 3, 2025 - BioSpace
Is Alto Neuroscience Inc. stock undervalued after correctionTrade Volume Summary & Long-Term Growth Plans - Newser
Can Alto Neuroscience Inc. stock double in next 5 yearsMarket Activity Report & Safe Investment Capital Preservation Plans - Newser
What technical patterns form on Alto Neuroscience Inc. stock chartsPortfolio Performance Summary & Step-by-Step Swing Trade Plans - Newser
Is Alto Neuroscience Inc. stock safe for risk averse investorsQuarterly Profit Report & AI Driven Price Forecasts - Newser
What dividend safety rating applies to Alto Neuroscience Inc. stockJuly 2025 PreEarnings & Real-Time Buy Zone Alerts - Newser
What sentiment indicators say about Alto Neuroscience Inc. stock - Newser
Alto Neuroscience (ANRO) Stock Analysis Report | Financials & Insights - Benzinga
Short Covering: Why Alto Neuroscience Inc. stock remains undervaluedJuly 2025 Action & Advanced Technical Signal Analysis - moha.gov.vn
Can Alto Neuroscience Inc. stock test all time highsLayoff News & Risk Controlled Stock Pick Alerts - Newser
Is Alto Neuroscience Inc. stock a buy during volatile markets2025 Key Lessons & Expert Approved Momentum Trade Ideas - Newser
How strong dollar benefits Alto Neuroscience Inc. stockJuly 2025 Review & Risk Controlled Stock Alerts - Newser
Johnson Fistel, PLLP Investigates Claims on Behalf of - GlobeNewswire
Biotech Co.'s Q3/25 Progress on Lead Programs Steady - streetwisereports.com
Biotech Co. Advances Precision Psychiatry Breakthrough Pipeline While Analysts' Sentiment Remains Positive - streetwisereports.com
Lost Money on Alto Neuroscience, Inc. (ANRO)? Contact Levi & Kors - The National Law Review
Alto Neuroscience: 4 Shots At Success In CNS Diseases In 2026 (NYSE:ANRO) - Seeking Alpha
Alto Neuroscience files to sell 8.45M shares of common stock for holders - TipRanks
Alto Neuroscience (NYSE: ANRO) files to register 8,454,514 resale shares from $50M private placement - Stock Titan
Alto Neuroscience’s ALTO-101 Study: A Potential Game-Changer for Schizophrenia Treatment? - MSN
Alto Neuroscience (NYSE:ANRO) Upgraded at Chardan Capital - MarketBeat
Alto Neuroscience Inc. (ANRO) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Why Alto Neuroscience Inc. stock attracts wealthy investorsJuly 2025 Levels & Technical Entry and Exit Tips - newser.com
How Alto Neuroscience Inc. stock expands through international marketsWeekly Trade Recap & Consistent Income Trade Recommendations - newser.com
Will Alto Neuroscience Inc. stock benefit from commodity prices2025 Technical Overview & Fast Momentum Entry Tips - newser.com
ANRO Builds Momentum: Pipeline Readouts And Cash Strategy Put 2026 In Spotlight - RTTNews
Quantitative breakdown of Alto Neuroscience Inc. recent move2025 Trading Volume Trends & Free Weekly Chart Analysis and Trade Guides - newser.com
Key resistance and support levels for Alto Neuroscience Inc.2025 Winners & Losers & Risk Managed Investment Strategies - newser.com
Volume spikes in Alto Neuroscience Inc. stock – what they mean - newser.com
Is Alto Neuroscience Inc. stock vulnerable to regulatory risksOptions Play & Scalable Portfolio Growth Ideas - newser.com
Alto Neuroscience Inc Azioni (ANRO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):